PRMT6 has been reported to be overexpressed in bladder, lung and breast cancer cells (Table 3) [44], and the elevated levels observed in breast tumor samples by immunohistochemistry (IHC) were correlated with tumor stage [120]. This evidence concerns the gene PRMT6 and breast carcinoma.